An insurance benefit that provides percutaneous coronary intervention patients with a discharge supply of antiplatelet medication could result in cost savings for insurers. To propose a model in which ...

Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new study has ...

An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a ...

Adding cilostazol - an antiplatelet medication used to treat leg pain - tended to prevent re-blockage of carotid artery stents within two years, according to late breaking science presented today at ...

Stent thrombosis is a rare, but serious, complication of modern percutaneous interventions, which could lead to MI and death. The extensive use of DESs has raised concern about late and very late ...

A new antiplatelet drug with a completely novel mechanism of action may hold the promise of delivering the holy grail ― reducing cardiac events without increasing bleeding. That is the hope behind the ...

DUBLIN--(BUSINESS WIRE)--The "Antiplatelet Market: Analysis By Drug Class, By Route of Administration, By Distribution Channel, By Region Size and Trends" report has been added to ...

When someone survives a heart attack, their recovery journey often includes a small pharmacy of medications—each serving a specific purpose in their healing process and long-term protection.

The application of antiplatelet therapy in dental surgery has become a focal point for clinicians due to the dual needs of maintaining thrombotic protection while minimising perioperative bleeding ...

MAYWOOD, IL - Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots ...